CTOs on the Move


 
Laxai is a South Plainfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.laxai.com
  • 4041A Hadley Rd
    South Plainfield, NJ USA 07080
  • Phone: 908.756.7300

Executives

Name Title Contact Details

Similar Companies

Hughes BioPharma Advisers

Hughes BioPharma Advisers is a Darien, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Eden Village Retirement Ctr

Eden Village Retirement Ctr is a Glen Carbon, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sunnyside Care Ctr

Sunnyside Care Ctr is a Lake Park, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Coloplast

Coloplast is among the world’s leading suppliers of intimate healthcare products and services. As a group, we have built our current position by listening to consumers and understanding their needs. For more than 50 years, Coloplast has developed and marketed innovative products that make life easier for people with diseases of a personal and private nature. Our focus is centered on ostomy care, continence care, urology care and skin and wound care.

Voyager Therapeutics

Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.